Detection of circulating tumor cells and their potential use as a biomarker for advanced renal cell carcinoma

Authors

  • Tae Heon Kim
  • Yoon-Tae Kang
  • Young-Ho Cho
  • Jeong Hoon Kim
  • Byong Chang Jeong
  • Seong Il Seo
  • Seong Soo Jeon
  • Hyun Moo Lee

Keywords:

circulating tumor cells, renal cell carcinoma, biomarker, survival, tapered-slit filter

Abstract

Introduction: The aim of this study was to detect circulating tumor cells (CTCs) in patients with advanced renal cell carcinoma (RCC) using a novel CTC detection platform. Furthermore, we evaluated the clinical outcomes associated with a CTC-positive status.

Methods: A total of 34 patients with advanced RCC (stage III or IV) were prospectively enrolled, and 104 peripheral blood samples were analyzed for the presence of CTCs at various time points. CTCs were isolated using a tapered-slit filter, which captures CTCs based on size and deformability. The presence of CTCs was confirmed using both staining and morphological criteria. CTC status was then correlated with clinical characteristics and survival outcomes.

Results: CTCs were detected in 62% of patients during the pretreatment period, and the median CTC count was 2 (interquartile range 1–3). During the followup period, CTCs were detected in 56% (18/32), 65% (20/31), and 41% (7/17) of patients at one week, one month, and three months after treatment, respectively. Overall, CTCs were found in 57.9% (66/114) of blood samples in the range of 1–7 cells. Although no statistical significance was found, CTC detection in patients with stage IV disease was more common than in patients with stage III disease (68.4% vs. 53.3%). Two-year progression-free survival and cancer-specific survival tended to be lower in CTCpositive patients compared with CTC-negative patients.

Conclusions: The tapered-slit filter is an efficient technique to detect CTCs in advanced RCC.

Downloads

Download data is not yet available.

Downloads

Published

2018-11-27

How to Cite

Kim, T. H., Kang, Y.-T., Cho, Y.-H., Kim, J. H., Jeong, B. C., Seo, S. I., Jeon, S. S., & Lee, H. M. (2018). Detection of circulating tumor cells and their potential use as a biomarker for advanced renal cell carcinoma. Canadian Urological Association Journal, 13(9). Retrieved from https://cuaj.ca/index.php/journal/article/view/5605

Issue

Vol. 13 No. 9 (2019): CUAJ September

Section

Original Research

License

You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:

  • Post the Article on any Web site
  • Translate or authorize a translation of the Article
  • Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
  • Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.

The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.

You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.

The CUA also requires you to warrant the following:

  • That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
  • That all individuals who have made a substantive contribution to the article are acknowledged;
  • That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
  • That the Article does not libel or violate the privacy rights of any third party.